NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 169 filers reported holding NOVAVAX INC in Q1 2015. The put-call ratio across all filers is 2.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $905,000 | -40.0% | 431,031 | +102.1% | 0.15% | -36.8% |
| Q3 2015 | $1,508,000 | -66.6% | 213,280 | -47.4% | 0.24% | -54.8% |
| Q2 2015 | $4,521,000 | +0.6% | 405,830 | -25.3% | 0.53% | +1.9% |
| Q1 2015 | $4,493,000 | +8.6% | 543,283 | -22.1% | 0.52% | -10.1% |
| Q4 2014 | $4,137,000 | +119.1% | 697,679 | +54.1% | 0.58% | +50.3% |
| Q3 2014 | $1,888,000 | -18.1% | 452,856 | -9.2% | 0.38% | -12.1% |
| Q2 2014 | $2,304,000 | -8.1% | 498,793 | -9.9% | 0.44% | -3.3% |
| Q1 2014 | $2,507,000 | -18.2% | 553,465 | -7.6% | 0.45% | -17.7% |
| Q4 2013 | $3,066,000 | +204.5% | 598,749 | +87.8% | 0.55% | +173.1% |
| Q3 2013 | $1,007,000 | – | 318,794 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |